Show an ad over header. AMP

I am the FIRST!!!

Biden on Supreme Court fight: "This is about whether or not the ACA will exist"

Joe Biden made health care the overwhelming focus of his remarks from Wilmington, Del., on Sunday, stressing that the Senate confirmation battle over Judge Amy Coney Barrett's nomination to the Supreme Court is about preserving the Affordable Care Act in the midst of a pandemic.

Why it matters: Democrats are aggressively pushing the message that Barrett, who has previously criticized Chief Justice John Roberts for his 2012 ruling salvaging the ACA, will seek to invalidate the law when the Supreme Court hears a Trump administration-backed lawsuit against it on Nov. 10.


  • President Trump himself tweeted on Sunday morning that the Supreme Court ending Obamacare would be a "big WIN" for the country.
  • Trump has said that he is in favor of protecting pre-existing conditions, but those protections are only at risk because of the Republican lawsuit to dismantle the ACA.

What they're saying: "The clear focus is, this is about your health care. This is about whether or not the ACA will exist. This is about whether or not pre-existing conditions will continue to be covered. This is about whether or not a woman can be charged more for the same procedure as a man. This is about people's health care in the middle of a pandemic," Biden said.

The big picture: Biden said he has not reached out to Senate Republicans to ask them to reconsider holding a confirmation vote before the election, but argued that the consequences will be seen at the ballot box. He declined to address whether he would support expanding the Supreme Court if Democrats take control of the Senate and White House.

Go deeper: Inside the Democrats' strategy for Barrett's confirmation fight

regular 4 post ff

infinite scroll 4 pff

Sanofi, GSK COVID vaccine shows strong immune response in phase 2 trials

Sanofi and GSK announcedthis morning their COVID-19 vaccine candidate demonstrated a strong immune response in adults in a phase 2 clinical trial.

Why it matters: Sanofi and GSK say their recombinant protein-based vaccine candidate could ultimately serve as a universal COVID-19 vaccine booster, able to boost immunity regardless of the vaccination first received.

Keep reading...Show less

Facebook says it will no longer remove posts claiming COVID is human-made

Facebook posts claiming that COVID-19 was "man-made" will no longer be removed, the social media giant announced Wednesday.

Why it matters: The lifting of the ban reflects a reinvigorated debate on the origins of the pandemic in recent days, following a Wall Street Journal report that three researchers at the Wuhan Institute of Virology were hospitalized in November 2019 after falling ill.

Keep reading...Show less

New memos show how top FDA officials thought slim evidence was enough for Alzheimer drug approval

FDA statisticians did not believe experimental Alzheimer's treatment Aduhelm proved that it could slow down the cognitive disease, but the top brass at the agency thought there was enough evidence to approve the drug anyway, according to internal documents released by the FDA today.

Why it matters: Outside experts almost unanimously voted down the drug, and the scientific community has blasted the FDA's approval of Aduhelm. But FDA leaders repeatedly cited "the urgent and unmet medical need" for Alzheimer's treatments.

Keep reading...Show less

New coalition forms to fight Republican legislature in Texas

Texas advocacy and political groups will launch a new coalition Monday to fight Republican efforts to change voting laws in their state and support Texans in need after the pandemic and last winter's paralyzing storm, Axios has learned.

Why it matters: While Democratic lawyers are fighting proposed or enacted changes in voting laws in battleground states, a grassroots response will be critical if the party and its backers hope to have any effects on the 2022 midterms and 2024 presidential election.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;